Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab vs placebo in males with low bone mineral density
2009-010205-37Phase 3Completed
- Sponsor
- Amgen
- Start
- Aug 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis and low bone mineral density comparing Denosumab arm with Placebo arm (2 arms). Primary endpoint: Percent change from baseline in lumbar spine BMD. Started Aug 2009; status: completed.
02
Drugs
denosumab
03
Conditions
osteoporosislow bone mineral density
Beyond the preview
Go deeper on 2009-010205-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010205-37.